Valo Health’s Post

Are you involved or interested in the #drugdevelopment space? The Center for Technology Licensing at Weill Cornell Medicine invites you to participate in a virtual #panel centered around a crucial topic at the forefront of #innovation in drug development. Thursday, May 30, 12-1pm ET: Join us for the next CTL@WCM Special Panel "Leveraging Alternatives to Animal Models to Transform Drug Development." About the panel: As we anticipate the new generation of human model systems coming to the forefront of drug development, including novel organoid, microphysiological, and in silico platforms, how can we begin to understand how far these systems can go in displacing animals, and what commercial and #regulatory challenges stand in their path? Especially as these cutting-edge technologies are gaining increasing scientific, commercial, and regulatory acceptance, accelerated by the passage of the FDA Modernization Act 2.0 in 2022. Join us as we convene a panel of experts in alternative human model systems to discuss their changing role in science and business. Panelists: •   Lowry Curley, Ph.D., Co-Founder and CEO of AxoSim •   Krista Durney, PhD, Associate Director, Innovation & Business Development at Valo Health •   Kristin Bircsak, Ph.D., Principal Scientist at MIMETAS •   Iris Bica, Business Development & Licensing Associate at Weill Cornell Medicine (Moderator) RSVP: https://lnkd.in/e3G5badK #lifesciences #animalmodels #organoids #biotech #businessdevelopment Iris B. Loren A. Busby, CFA Qian Hua Ge Center for Technology Licensing at Cornell University (CTL)